1-1Bakhtiar, R.; Nelson, R. W. ²Electrospray ionization and matrix-assisted laser desorption ionization mass spectrometry², Biochemical Pharmacology, 2000, 59, 891-905.
1-2陳怡婷，凌永健，「基質輔助雷射脫附離子化質譜術」，科儀新知，1997年8月，第19卷第1期，60-70頁。1-3史世華，「基質輔助雷射脫附游離─飛行時間質譜技術及其應用」，科儀新知，1999年6月，第20卷第6期，70-80頁。
1-4蘇瑀，「防治阿滋海默式症之中草藥研發的現況與展望」，生物醫學報導，2000年5月，第7期，8-9頁。
2-1Qureshi, G. A.; Bednar, I.; Min, Q.; Sodersten, P.; Silberring, J.; Nyberg, F.; Thornwall, M. ²Quantitation and identification of 2 cholecystokinin peptides, cck-4 and cck-8s, in rat-brain by HPLC and fast-atom-bombardment mass-spectrometry², Biomed. Chromatogr. 1993, 7, 251-255.
2-2Facino, R. M.; Carini, M.; Aldini, G.; Colombo, L. ²Characterization of the intermediate products of lipid peroxidation in phosphatidylcholine liposomes by fast-atom bombardment mass spectrometry and tandem mass spectrometry techniques², Rapid Commun. Mass Spectrom. 1996, 10, 1148-1152.
2-3Greig, M. J.; Gaus, H.; Cummins, L. L.; Sasmor, H.; Griffey, R. H. ²Measurement of macromolecular binding using electrospray mass-spectrometry - determination of dissociation-constants for oligonucleotide-serum albumin complexes², J. Am. Chem. Soc. 1995, 117, 10765-10766.
2-4Dudley, E.; El-Sharkawi, S.; Games, D. E.;, Newton, R. P. ²Analysis of urinary nucleosides. I. Optimization of high performance liquid chromatography/electrospray mass spectrometry², Rapid Commun. Mass Spectrom. 2000, 14, 1200-1207.
2-5Sutton, C. W.; Wheeler, C. H.; Corbett, J. M.; Cottrell, J. S.; Dunn, M. J. ²The analysis of myocardial proteins by infrared and ultraviolet laser desorption mass spectrometry², Electrophoresis. 1997, 18, 424-431.
2-6Han, M.; Sunner, J. ²An activated carbon substrate surface for laser desorption mass spectrometry², J. Am. Soc. Mass Spectrom. 2000, 11, 644-649.
2-7Wattenberg, A.; Sobott, F.; Brutschy, B. ²Detection of intact hemoglobin from aqueous solution with laser desorption mass spectrometry², Rapid Commun. Mass Spectrom. 2000, 14, 859-821.
2-8Koomen, J. M.; Russell, W. K.; Hettick, J. M.; Russell, D. H. ²Improvement of resolution, mass accuracy, and reproducibility in reflected mode DE-MALDI-TOF analysis of DNA using cast evaporation-overlayer sample preparations², Anal. Chem. 2000, 72, 3860-3866.
2-9Kasai, P. H.; Spool, A. M. ²Perfluoro-poly(ethers) with hydroxyl end groups: Analysis by TOF-SIMS², J. Phys. Chem. B. 1998, 102, 7331-7337.
2-10Zeng, X. M.; Chan, C. M.; Weng, L. T.; Li, L. ²Surface characterization and quantitative study of poly(4-vinyl phenol) and poly(4-vinyl pyridine) blends by XPS and TOF-SIMS², Polymer. 2000, 41, 8321-8329.
2-11Domingues, M. R. M.; Santana-Marques, M. G.; Ferrrer-Correia, A. J.; Tome, A. C.; Neves, M. G. P. M. S.; Cavaleiro, J. A. S. ²Liquid secondary ion mass spectrometry and collision-induced dissociation mass spectrometry of sulfonamide derivatives of meso-tetraphenylporphyrin², J. Porphyr. Phthalocya. 1999, 3, 172-179.
2-12Duncan, M. W.; Matanovic, G.; Cerpa-Poljak. A. ²Quantitative-analysis of low-molecular-weight compounds of biological interest by matrix-assisted laser-desorption ionization², Rapid Commun. Mass Spectrom. 1993, 7, 1090-1094.
2-13Lidgard, R.; Duncan, M. W. ²Utility of matrix-assisted laser-desorption ionization time-of-flight mass-spectrometry for the analysis of low-molecular-weight compounds², Rapid Commun. Mass Spectrom. 1995, 9, 128-132.
2-14Nicola, A. J.; Gusev, A. I.; Hercules, D. M. ²Direct quantitative analysis from thin-layer chromatography plates using matrix-assisted laser desorption/ionization mass spectrometry², Appl. Spectrosc. 1996, 50, 1479-1482.
2-15Goheen, S. C.; Wahl, K. L.; Campbell, J. A.; Hess, W. P. ²Mass spectrometry of low molecular mass solids by matrix-assisted laser desorption/ionization², J. Mass Spectrom. 1997, 32, 820-828.
2-16Hilaire, P. M. S.; Cipolla, L.; Tedebark, U.; Meldal, M. ²Analysis of organic reactions by thin layer chromatography combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry², Rapid Commun. Mass Spectrom. 1998, 12, 1475-1484.
2-17Fukai,T.; Kuroda, J.; Nomura. T. ²Accurate mass measurement of low molecular weight compounds by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry”. J. Am. Soc Mass Spectrom. 2000, 11, 458-463.
2-18Cotter, R. J.; ²Time-of Flight Mass Spectrometry：Instrumentation and applications in biological research², American Chemical Society., Washington, DC. 1997, P26.
2-19Cotter, R. J.; ²Time-of-Flight Mass Spectrometry², American Chemical Society., Washington, 1994.
2-20陳怡婷、凌永健，「基質輔助雷射脫附離子化質譜術」，科儀新知，1997，第十九卷一期，60-70頁。2-21Wiley, W. C.; McLaren, I. H. ²Time-of-Flight Mass Spectrometry with Improved Resolution², Rev. Sci. Instrum. 1955, 26, 1150-1157.
2-22Karas, M. ²‘Time-of-Flight Mass Spectrometry with Improved Resolution, ’W. C. Wiley and I. H. Mclaren, Rev. Sci. Instrum., 26, 1150(1955)², J. Mass Spectrom. 1997, 32, 1-3.
2-23Voyager Biospectrometry workstation User’s Guide. Per-Septive Biosystems, Inc. MA, USA. 1999.
2-24Edmondson, R. D.; Russell, D. H. ²Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass measurement accuracy by using delayed extraction², J. Am. Soc. Mass Spectrom. 1996, 7, 995-1001.
2-25 Wingerath, T.; Kirsch, D.; Kaufmann, R.; Stahl, W.; Sies, H ²Matrix-assisted laser desorption-postsource decay-mass spectrometry², Method in Enzymology, 1999, 299, 390-408.
2-26Sadagopan, N.; Watson, J. T. ²Mass spectrometric evidence for mechanisms of fragmentation of charge-derivatized peptides², J. Am. Soc. Mass Spectrom. 2001, 12, 399-409.
2-27Karas, M.; Hillenkamp, F. ²Laser desorption Ionization of proteins with molecular mass exceeding 10,000 Daltons², Anal. Chem. 1988, 60, 2299-2301.
2-28Tanaka, K.; Waki, H.; Ido, Y.; Akita, S.; Yoshida, Y.; Toshida, T. ²Protein and polymer analyses up to m/z 100,000 by laser ionization time-flight mass spectrometry², Rapid Commun. Mass Spectrom. 1988, 2, 151-153.
2-29Beavis, R. C.; Chait, B. T. ²High-accuracy molecular mass determination of proteins using matrix-assisted laser desorption mass-spectrometry², Anal Chem. 1990, 62, 1836-1840.
2-30Han, M.; Sunner, J. ²An activated carbon substrate surface for laser desorption mass spectrometry², J. Am. Soc. Mass Spectrom. 2000, 11, 644-649.
2-31HP Help A.03.00（SW a.03.00）Jul 96.
2-32Allwood, D. A.; Dreyfus, R. W.; Perera, I. K.; Dyer, P. E. ²UV Optical absorption of matrices used for matrix-assisted laser desorption/Ionization², Rapid Commun. Mass Spectrom. 1996, 10, 1575-1578.
2-33Jespersen, S.; Niessen, W. M. A.; Tjaden, U. R.; van der Greef, J. ²Quantitative bioanalysus using Matix-assistedbLaser Desorption/Ionization Mass Spectrometry², J. Mass Spectrom. 1995, 30, 357-364.
2-34Camafeita, E.; Alfonso, P.; Acevedo, B.; Méndez, E. ²Sample Preparation Optimization for the analysis of Gliadins in Food by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry², J. Mass Spectrom. 1997, 30, 444-449.
2-35Xu, N.; Huang, Z. H.; Watson, J. T.; Gage, D. A. ²Mercaptobenzothiazoles: A New Class of Matrices for Laser Desorption Ionization Mass Spectrometry², J. Am. Soc. Mass Spectrom. 1997, 8, 116-124.
2-36Sheffer, J. D.; Murray, K. K. ²Infrared matrix-assisted laser desorption/ionization using OH, NH and CH vibrational absorption², Rapid Commun. Mass Spectrom. 1998, 12, 1685-1890.
2-37Beavis, R. C. ²Matrix-assisted ultraviolet laser deorption: evolution and principles², Org. Mass Spectrom. 1992, 27, 653-659.
2-38Zenobi, R.; Knochenmuss, R. ²Ion formation in MALDI mass spectrometry², Mass Spectrometry Reviews, 1998, 17, 337-366.
2-39Nielen, M. W. F. ²MALDI time-of-flight mass spectrometry of synthetic polymers², Mass Spectrometry Reviews, 1999, 18, 309-344.
2-40Allwood, D. A.; Dyer, P. E.; Dreyfus, R. W. ²Ionization modelling of matrix molecules in ultraviolet matrix-assisted laser desorption/ionization², Rapid Commun. Mass Spectrom. 1997, 11, 499-503.
2-41Lehmann, E.; Knochenmuss, R.; Zenobi, R. ²Ionization mechanisms in matrix-assisted laser desorption/ionization mass spectrometry:contribution of preformed ions², Rapid Commun. Mass Spectrom. 1997, 11, 1483-1492.
2-42Calba, R. J.; Muller, J. F.; Inouye, M. ²H-atom transfer following analyte photoionization in matrix-assisted laser desorption/ionization processes², Rapid Commun. Mass Spectrom. 1998, 12, 1727-1741
2-43Ehring, H.; Karas, M.; Hillenkamp, F. ²Role of photoionization and photochemistry in ionization processes of organic molecules and relevance for matrix-assisted laser desorption ionization mass spectrometry², Org. Mass Spectrom. 1992, 27, 472-480.
2-44Knochenmuss, R.; Dubois, F.; Dale, M. J.; Zenobi, R. ²The matrix suppression effect and ionization mechanisms in matrix-assisted laser desorption/ionization², Rapid Commun. Mass Spectrom. 1996, 10, 871-877.
2-45Gusev, A. I.; Wilkinson, W. R.; Proctor, A.; Hercules, D. M. ²Improvenment of signal reproducibility and matrix/comatrix effects in MALDI analysis², Anal. Chem. 1995, 67, 1034-1041.
2-46Dai, Y.; Randy, M.; Li, L. ²Two-layer sample preparation: a method for MALDI-MS analysis of complex peptide and protein mixtures², Anal. Chem. 1999, 71, 1087-1091.
2-47Pastor, S. J.; Wilkins, C. L. ²Analysis of hydrocarbon polymers by matrix-assisted laser desorption/ionization Fourier transform mass spectrometry², J. Am. Soc. Mass Spectrom. 1997, 8, 225-133.
2-48Little, D. P.; Cornish, T. J.; O’Donnell, M. J.; Braun, A.; Cotter, R. J.; Köster, H. ²MALDI on a chip: Analysis of arrays of low femtomole to subfemtomole quantities of synthetic oligonucleotides and DNA diagnostic products dispensed by a piezoelectric pipet², Anal. Chem. 1997, 69, 4540-4546.
2-49Li, L. J.; Garden, R. W.; Romanova, E. V.; Sweedler, J. V. ²In situ sequencing of peptides from biological tissues and single cells using MALDI-PSD/CID analysis². Anal. Chem. 1999, 71, 5451-5458.
2-50Nanda, A. K.; Ganesh, K.; Kishore, K.; Surinarayanan, M. ²End-group analysis of vinyl polyperoxides by MALDI-TOF-MS, FT-IR technique and thermochemical calculations², Polymer. 2000, 419063-9072.
2-51Vitamin receptors: Vitamins as ligands in cell communication, K. Dakshinamurti, Cambridge University Press, 1994. Great Britain.
2-52Vitamins and your health, A. Gildroy, George Allen & Unwin, 1982. Great Britain.
2-53Bates, C. J. ²Vitamin analysis², Ann Clin Biochem. 1997, 34, 599-626.
2-54Pal, T.; Anantha Narayanan, V.; Stokes, D. L.; Vo-Dinh T. ²Surface-enhanced Raman detection of nicotinamide in vitamin tablets², Anal. Chem. Acta. 1998, 368, 21-28.
2-55Gilpin, R. K.; Pachla, L. A. ²Pharmaceuticals and related drugs², Anal. Chem. 1999, 71, 217R-233R.
2-56Solouki, T.; Russell, D. H. ²Structural mass-spectrometry of matrix-assisted laser-desorbed biomolecules by fourier-transform ion-cyclotron resonance mass-spectrometry - photoionization and photofragmentation², Appl. Spectrosc. 1993, 47, 211-217.
2-57Kinsel, G. R.; Preston, L. M.; Russell, D. H. ²Fragmentation of vitamin-b-12 during 337 nm matrix-assisted laser-desorption ionization², Biol. Mass Spectrom. 1994, 23, 205-211.
2-58He, L.; Wei, G.; Murray, K. K. ²Fragmentation of vitamin B-12 in aerosol matrix-assisted laser desorption ionization², J. Am. Soc. Mass Spectrom. 1997, 8, 140-147.
2-59Database of nutritional ingredients in food collected from Taiwan area, Department of Health, Republic of China, 1998.
2-60Lavallee, D. K. ²The chemistry and biochemistry of N-substituted porphyrins², VCH Publishers, Inc., New York, 1987.
2-61Dailey, H. A. ²Biosynthesis of heme and chlorophylls², McGraw-Hill, Inc., New York, 1990.
2-62Sessler, J. L.; Weghorn, S. J. ²Expanded, contracted & isomeric porphyrins², Elsevier Science Inc., New York, 1997.
2-63Sternberg, E. D.; Dolphin, D. Bruckner, C. ²Porphyrin-based photosensitizers for use in photodynamic therapy², Tetrahedron. 1998, 54, 4151-4202.
2-64Lidgard, R.; Duncan, M. W. ²Utility of matrix-assisted laser-desorption ionization time-of-flight mass-spectrometry for the analysis of low-molecular-weight compounds², Rapid Commun. Mass Spectrom. 1995, 9, 128-132.
2-65Jones, R. M.; Lamb, J. H.; Lim, C. K. ²Urinary porphyrin profiles by laser-desorption ionization time-of-flight mass-spectrometry without the use of classical matrices², Rapid Commun. Mass Spectrom. 1995, 9, 921-923.
2-66Smith, K. M. Porphyrins and Metalloporphyrins, Ed., Elsevier, Amsterdam, 1975, 1-910.
2-67Breuker, K.; Knochenmuss, R.; Zenoi, R. ²Proton transfer reactions of matrix-assisted laser desorption/ionization matrix monomers and dimers², J. Am. Soc. Mass Spectrom. 1999, 10, 1111-1123.
2-68Jones, R. M.; Lamb, J. H.; Lim, C. K. ²5,10,15,20-meso-tetra(hydroxyphenyl)chlorin as a matrix for the analysis of low-molecular-weight compounds by matrix-assisted laser-desorption ionization time-of-flight mass-spectrometry², Rapid Commun. Mass Spectrom. 1995, 9, 968-969.
2-69Ling, Y. C.; Lin, L.; Chen, Y. T. ²Quantitative analysis of antibiotics by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry², Rapid Commun. Mass Spectrom. 1998, 12, 317-327.
2-70Ayorinde, F. O.; Hambright, P.; Porter, T. N.; Keith Jr. Q. L. ²Use of meso- tetrakis(pentafluorophenyl)porphyrin as a matrix for low molecular weight alkylphenol ethoxylates in laser desorption/ ionization time-of-flight mass spectrometry², Rapid Commun. Mass Spectrom. 1999, 13, 2474-2479.
2-71Cohen, S. L.; Chait, B. T. ²Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins ², Anal. Chem. 1996, 68, 31-37.
2-72Schriemer, D. C.; Li, L. ²Detection of high molecular weight narrow polydisperse polymers up to 1.5 million Daltons by MALDI mass spectrometry², Anal.Chem. 1996, 68, 2721-2725.
2-73Yalcin, T.; Schriemer, D. C.; Li, L. ²Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the analysis of polydienes², J. Am. Soc. Mass Spectrom. 1997, 8, 1220-1229.
2-74Kinsel, G. R.; Preston, L. M.; Russell, D. H. ²Fragmentation of vitamin B12 during 337 nm matrix-assisted laser desorption Ionization², Bio. Mass Spectrom. 1994, 23, 205-211.
2-75He, L.; Wei, G.; Murray, K. K. ²Fragmentation of vitamin B12 in aerosol matrix-assisted laser desorption desorption ionization², J. Am. Soc. Mass Spectrom. 1997, 8, 140-147.
2-76Tang K.; Allman, S. L.; Jones, R. B.; Chen, C. H. ² Quantitative-analysis of biopolymers by matrix-assisted laser-desorption², Anal. Chem. 1993, 65, 2164-2166.
2-77Nelson, R. W.; McLean, M. A.; Hutchens, T. W. ² Quantitative-determination of proteins by matrix-assisted laser-desorption ionization time-of-flight mass-spectrometry ², Anal. Chem. 1994, 66, 1408-1415.
2-78Muddiman, D. C.; Gusev, A. I.; Proctor, A.; Hercules. D. M.; Venkataramanan. R.; Diven, W. ²Quantitative measurement of cyclosporine-a in blood by time-of-flight mass-spectrometry², Anal. Chem. 1994, 66, 2362-2368.
2-79Tang, X. D.; Sadeghi, M. E.; Olumee, Z.; Vertes, A.; Braatz, J. A.; Mcilwain, L. K.; Dreifuss, P. A. ²Detection and quantitation of beta-2-microglobulin glycosylated end products in human serum by matrix-assisted laser desorption/ionization mass spectrometry², Anal. Chem. 1996, 68, 3740-3745.
2-80Hensel, R. R.; King, R. C.; Owens, K. G. ²Electrospray sample preparation for improved quantitation in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry², Rapid Commun. Mass Spectrom. 1997, 11, 1785-1793.
2-81Pitt, J. J.; Gorman, J. J. ²Oligosaccharide characterization and quantitation using 1-phenyl-3-methyl-5-pyrazolone derivatization and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry², Anal. Biochem. 1997, 248, 63-75.
2-82Scamporrino, E.; Maravigna, P.; Vitalini, D.; Mineo, P. ² A new procedure for quantitative correction of matrix-assisted laser desorption/ionization time-of-flight mass spectrometric response², Rapid Commun. Mass Spectrom. 1998, 12, 646-650.
2-83Sugiyama, E.; Hara, A.; Uemura, K. ²A quantitative analysis of serum sulfatide by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction², Anal. Biochem. 1999, 274, 90-97.
2-84Wilkinson, W. R.; Gusev, A. I.; Proctor, A.; Houalla, M.; Hercules, D. M. ²Selection of internal standards for quantitative analysis by matrix assisted laser desorption ionization (MALDI) time-of-flight mass spectrometry², Fresenius J. Anal. Chem. 1997, 357, 241-248.
2-85Boyd, R. K. ²Quantitative trace analysis by combined chromatography and mass-spectrometry using external and internal standards², Rapid Commun. Mass Spectrom. 1993, 7, 257-271.
2-86王勝盟，「簡化前處理技術配合質譜術分析安非他命類藥物之研究」，國立清華大學博士論文，1997。
2-87Skoog, D. A.; Leary, J. J. ²Principle of Instrumental Analysis², Fourth edition, Saunders College Publishing, Florida, USA, 1992.
2-88Schiewe, J.; Mrestani, Y.; Neubert, R. ²Application and optimization of capillary zone electrophoresis in vitamin analysis², J. Chromatogr. A. 1995, 717, 255-259.
3-1王東釧、王威翔。「光碟之規格與結構」，工業材料，1999年6月，150期，139-149頁。3-2「光碟片產業」。彰銀資料，1999年9月，第48卷9期，75-81頁。
3-3宋小敏、顏光甫。「可錄一次式光碟（CD-R）之材料及技術」，電子月刊，1999年6月，第5卷第6期，82-93頁。3-4 張維志。「國內CD-R光碟片發展前景」，工業材料，2000年3月，第159期，88-90頁。3-5尤明灝，「我國光電產業及光儲存媒體之現況及展望」，華銀月刊，2001年8月，第607期，22-38頁。
3-6曾淑華，「CD-R光碟片仍是記錄型光碟片市場主流」，工業材料雜誌，2001年4月，第172期，115-119頁。
3-7林川欽，「光碟片產業探析」，台研兩岸產業與投資，1990年9月，第16期，46-52頁。
3-8張家瑋，「光碟片用材料/化學品市場及技術轉移」，化工資訊，2000年7月，第14卷第7期，16~24頁。
3-9「光碟片產業」，產業經濟，2000年10月，第230卷，66-72頁。
3-10經濟部ITIS產業資訊服務網，http://www.itis.itri.org.tw/。
3-11顏豐文，「光記錄媒體染料之設計與未來發展趨勢」，工業材料雜誌，2001年4月，第172期，173-178頁。
3-12張寶華，「全球記錄媒體化學材料市場概況」，化工資訊，1998年8月，56-60頁。
3-13高潁真，「可溶性Phthalocyanine的合成及其光電功能研究」，國立清華大學碩士論文，1999年。
3-14「CD-R產業 染料見真章」，經濟日報，2000年4月15日，週末版。
3-15Achar, B. N.; Fohlen, G. M.; Hsu, M. S.; Parker, J. A. ²Mass spectroscopy of epoxylated novolac resin cured with phthalocyanine tetraamines²., J. Polymer Sci. 1984, 22, 1471-1479.
3-16Dale, M. J.; Jones, A. C.; Langridgesmith, P. R. R.; Costello, K. F.; Cummins, P. G. ²Laser desorption laser photoionization time-of-flight mass-spectrometry of dyes²., Anal. Chem. 1993, 65, 793-801.
3-17Schuerlein, T. J.; Armstrong, N. R. ²Formation and characterization of epitaxial phthalocyanine and perylene monolayers and bilayers on Cu(100) - low-energy-electron diffraction and thermal-desorption mass-spectrometry studies²., Journal of vacuum science & Technology A-Vacuum Surfaces and Films. 1994, 12, 1992-1997.
3-18Schildcrout, S. M. ²Temperature-dependent single vs. double ionization in the mass spectra of phthalocyanine and its metal(II) complex²., J. Am. Chem. Soc. 1998, 105, 3852-3855.
3-19Fenyo, D.; Chait, B. T.; Johnson, T. E.; Lindsey, J. S. ²Laser desorption mass spectrometry of synthetic multiporphyrin arrays², J. of Porphyrins and Phthalocyanines. 1997, 1, 93-98.
3-20Srinivasan, N.; Haney, C. A.; Lindsey, J. S.; Zhang, W.; Chait, B. ²Investigation of MALDI-TOF mass spectrometry of diverse synthetic metalloporphyrins, phthalocyanines and multiporphyrin arrays², J. of Porphyrins and Phthalocyanines. 1999, 3, 283-291.
3-21Mckeown, N. B. ²Phthalocyanine Materials：synthesis, structure and function², Cambridge University Press, UK. 1998.
3-22Leznoff, C. C.; Lever, A. B. P. ²Phthalocyanines：properties and applications², Voim4, VCH Publishers, Inc.,USA. 1996.
3-23Oguchi T.; Umehara, H.; Sugimoto, K.; Oi, R.; Itoh, H.; ²Phthalocyanine compound and optical recording medium containing it², United States Patent Number:5,646,273. Jul. 8, 1997.
4-1林育娟，「阿耳滋海默氏症之病因與治療」，臨床醫學，1996年，第38卷第6期，420-428頁。
4-2陸景玉，「失智症及其相關之診斷與藥物治療」，產業調查與技術，1990年，第132期，27-34頁。
4-3葉炳強，「失智症是什麼」，老年失智症學術研討會論文集，1996年4月。
4-4邱銘章，「認識老年痴呆症」，健康教育，1993年，第72期，3-9頁。
4-5葉炳強，「異常老年期腦部退化的代表¾阿爾茲海瑪氏病」，73，1992年，58-61頁。
4-6林健群，「失智症的分類及診斷」，國防醫學，1998年1月，第26卷第1期，3-7頁。
4-7Wen, G. Y. ²Alzheimer’s disease and risk factors², J. Food and Drug Analysis. 1998, 6, 465-476.
4-8Sussman, J. L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. ²Atomic structure of acetylcholinesterase from Torpedo californica：a prototypic acetylcholine-binding protein², Science. 1991, 253, 872-879.
4-9行政院主計處，中華民國統計月報，2001年3月。
4-10藍恩玲，「阿滋海默氏病及其他老年失智症之藥物治療」，醫院藥學，1998年3月，第15卷第1、2期，113-119頁。
4-11劉景寬，中華民國神經醫學會會刊，1998年。
4-12葉炳強、孟玲玲，「台灣地區的老年癡呆人口有多少？」，健康教育，1993年，第72卷，10-15頁。
4-13傅中玲，「阿滋海默氏病的經濟成本」，老年失智症學術研討會論文集，1995年4月。
4-14劉秀枝、翁文章、王署君，「阿茲海默氏症之能之藥物治療」，應用心理研究，2000年，第7期，119-132頁。4-15Sramek, J. J.; Culter, N. R. ²Recent developments in the drug treatment of Alzheimer’s disease², Drug & Aging. 1999, 14, 359-373.
4-16邱銘章，「癡呆症藥物治療的趨勢與展望」，1996年，29，1-7頁。
4-17李慧瓊，「老年痴呆症─阿耳滋海默氏疾病治療的現況」，藥學雜誌，1995年3月，第11卷第2期，72-77頁。
4-18陳昭姿，「Donepezil（Aricept®）─治療阿茲海默症的新藥」，當代醫學，1998年12月，第25卷第12期，49-51頁。
4-19莊玲菁，「Donepezil（Aricept®）─治療Alzheimer’s disease的新藥」，藥學雜誌，1999年，61期，93-95頁。
4-20Perry, E. K.; Pickering, A. T.; Wang, W. W.; Houghton, P. J.; Perry, N. S. L. ²Medicinal plants and Alzheimer’s disease：from ethnobotany to phytotherapy², J. Pharm. Pharmacol. 1999, 51, 527-534.
4-21Bierer, L. M.; Haroutunian, V.; Gabriel, S.; Knott, P. J.; Carlin, L. S.; Purohit, D. P.; Perl, D. P.; Schmeidler, J.; Kanof, P.; Davis, K. L. ²Neutrochemical correlates of dementia severity in Alzheimer’s disease：Relative importance of the cholinergic deficits², J. of Neurochemistry. 1995, 64, 749-760.
4-22Wilock, G.; Wilkinson, D. Galanthamine hydrobromide :interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnose of senile dementia of the Alzheimer type. In: Iqbal, K.; Winblad, B.; Nishimura, T. et al. editors. Alzheimers disease: biology, diagnosis and therapeutics. New York: Wiley, 1997; 661-664.
4-23Tang, X. C.; Kindel, G. H.; Kozikowski, A. P.; Hanin, I. ²Comparison of the effects of natural and synthetic huperzine-A on rat brain cholinergic function in vitro and in vivo², J. Ethnopharmacol. 1994, 44, 147-155.
4-24Cheng, D. H.; Tang, X. C. ²Comparative studies of huperzine A, E2020, and tacrine behavior and cholinesterase activities², Pharmacol. Biochem. Behav. 1998, 60, 377-386.
4-25Wang, T.; Tang, X. C. ²Reversal of scopolamine-induced deficits in radical maze performance by (-)-huperzine A: comparison with E2020 and tarcine², Eur. J. Pharmacol. 1998, 349, 137-142.
4-26鄭奕帝，「Metrifonate一種治療阿茲海默症（Alzheimer’s disease, AD）的新藥」，藥學雜誌，1999年，第15卷第4期，96-101頁。
4-27Ott, A.; Slooter, A. J.; Hofman, A. ²Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam study², Lancet. 1998, 351, 1840-1843.
4-28Hillier, V.; Salib, E. ²A case-control study of smoking and Alzheimer’s disease², Int. J. Geriatr. Psychiatry. 1997, 12, 295-300.
4-29Brenner, D. E.; Kukull, W. A.; van Belle, G.; Bowen, J. D.; McCormick, W. C.; Teri, L.; Larson, E. B. ²Relationship between cigarette smoking and Alzheimer’s disease in a population-based case-control study², Neurology. 1993, 43, 293-300.
4-30Sano, M.; Ernesto, C.; Tomas, R. G.; Klauber, M. R.; Schafer, K.; Grundman, M.; Woodbury, P.; Growdon, J.; Cotman, C. W.; Pfeiffer, E.; Schneider, L. S.; Thal, L. J. ²A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease ², The New England Journal of Medicine. 1997, 336, 1216-1222.
4-31Mordente, A.; Martorana, G. E.; Minotti, G. et al. ²Antioxidant properties of 2,3-dimethoxy-5-methyl-6-（10-hydroxygecyl）-1,4-benzoquinone（idebenone）², Chem. Res. Toxicol. 1998, 11, 54-63.
4-32Vesselin, D. P.; Rumen, K.; Stiljana, B.; Elena, K.; Vesselin, V. P.; Damjanka, G.; Victoria, M. ²Memory effects of standardized extracts of panax ginseng（G115）, Ginkgo biloba（GK501） and their combination gincosan（PHL-00701）², Planta Med. 1992, 59, 106-114.
4-33Joyeux, M.; Lobstein, A.; Anton, R.; Mortier, F. ²Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo and some flavonoids², Planta Med. 1995, 61, 126-129.
4-34Simpkins, J. W.; Green, P. S.; Gridley, K. E.; et al. ²Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer’s disease², Am. J. Med. 1997, 103（3A）, 19S-25.
4-35Brenner, D. E.; Kukull, W. A.; Stergachis, A.; at al. ²Postmenopausal estrogen replacement therapy and the risk of Alzheimer’s disease：a population-based case-control study², Am. J. Epidemiol. 1994, 149, 262-267.
4-36Anderson, K.; Launer, L. J.; Ott, A.; at el. ²Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer’s disease?², The Rotterdam Study. Neurology. 1995, 45, 1441-1445.
4-37Aisen, P. S.; Davis, K. L. ²Anti-inflammatory therapy for Alzheimer’s disease: a status report ², International Journal of Geriatric Psychopharmacology. 1997, 1, 2-5.
4-38Dietary Supplement Health and Education Act of 1994, USA.
4-39鄭慧文，http://www.health.nsysu.edu.tw/fdaglobe/flaw_010.htm.
4-40Mitscher, L. A.; Pillai, S.; Shankel, D. M. ²Some transpacific thoughts on the regulatory need for standarization fo herbal medical products², Journal of Food and Drug Analysis. 2000, 8, 229-234.
4-41Lee, K. H.; Wang, H. K.; Itokawa, H.; Morris-Natschke, S. L. ²Current perspectives on Chinese medicines and dietary supplements in China, Japan and United States², Journal of Food and Drug Analysis. 2000, 8, 219-228.
4-42蕭照貞、邱哲傑，「日本漢方藥產業概況」，野村總和研究所台北分公司，1999年6月10日。
4-43http://www.nutritionno1.com/article/art-g-news/html/nut-news-20001120a.htm；http://www.consumer.org.hk/p289c.htm.
4-44鄭綜程，「銀杏葉製劑的發展史」，台北市藥師工會會刊，1995年8月，第13卷第5期，1-2頁。
4-45江淑芬，「淺談中草藥世界市場概況」，科技與生活，2000年3月，38-41頁。
4-46蔡幸作，「中草藥之化學、製造與管制」，中草藥科技化研討會論文摘要集，2000年12月9日，38-39頁。
4-47自立晚報，「衛署籌建中草藥科技研究中心」，2001年1月17日，第4版。
4-48張成國，「中草藥生物科技發展趨勢與商機」，中草藥科技化研討會論文摘要集，2000年12月9日，2-5頁。
4-49尹福秀，「中草藥發展之推動與展望」，中草藥科技化研討會論文摘要集，2000年12月9日，7-16頁。
4-50http://www.zybh.gov.cn/info002.htm.
4-51Zuess, J.; ²Ginkgo, the smart herb², Three Rivers Press, New York, 1998.
4-52萊斯莉‧布倫尼斯著，「藥用植物圖鑑」，貓頭鷹出版社，1998年2月出版三刷，57頁。
4-53Furukawa, S.; Sci. Papers Inst. Phys. Chem. Res. Tokyo, 1932, 19, 27.
4-54(1)Nakanishi, K. Pure Appl. Chem. 1967, 14, 89.
(2)Okabe, O.; Yamada, K.; Takada, S. J. Chem. Soc. C 1967, 21, 2201-2206.
4-55Braquet, P.; Esanu, A.; Buisine, E.; Hosford, D.; Broquet, C.; Koltai, M. ²Recent progress in ginkgolide research², Medicinal Research Reviews, 1991, 11, 299-355.
4-56Kleijnen, J.; Knipschild, P. ²Ginkgo biloba², Lancet. 1992, 340, 1136-1139.
4-57洪傳岳、黃怡超、邱仁輝，「中醫藥現代化：研究論文評介」，橘井文化事業股份有限公司，1999年1月初版，14-16頁。
4-58Braquet, P.; Esanu, A.; Buisine, E.; Hosford, D.; Broquet, C.; Koltai, M. ²Recent progress in ginkgolide research², Medicinal Research Reviews. 1991, 11, 295-355.
4-59董成宏，「銀杏葉萃出物之生理功效」，科學與技術，2000年，第32卷第2期，61-67頁。
4-60Yan, L. J.; Droy-Lefaix, M. T.; Packer, L. ²Ginkgo bilobalide extract（EGB 761）protects human low density lipoproteins against oxidative modification mediated by copper², Biochemical and Biophysical Communications. 1995, 212, 360-366.
4-61²WHO monographs on Selected medicinal plants², World Health Organization, Geneva, 1999, Volume 1, 154-167.
4-62Petkov, V. D.; Kehayov, R.; Belcheva, S.; Konstantinova, E.; Petkov, V. V.; Getova, D.; Markovska, V. ²Memory effects of standardized extracts of Panax ginseng（G115）, Ginkgo biloba（GK 501）and their combination Gincosanâ（PHL-00701）², Planta Med. 1993, 59, 106-114.
4-63Maurer, K.; Ihl, R.; Dierks, T.; Frölich, L. ²Clinical efficacy of Ginkgo biloba special extract EGB 761 in dementia of the Alzheimer type², J. Psychiat. Res. 1997, 31, 645-655.
4-64Oken, B. S.; Storzbach, D. M.; Kaye, J. A. ²The effect of Ginkgo biloba on cognitive function in Alzheimer disease², Arch Neutrol. 1998, 55, 1409-1415.
4-65Marcocci, L.; Maguire, J. J.; Droy-Lefaix, M. T.; Packer, L. ²The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761², Biochemical and Biophysical Research Communications. 1994, 201, 748-755.
4-66Marcocci, L.; Packer, L.; Droy-Lefaix, M. T.; Sekaki, A.; Gardés-Albert, M. ²Antioxidant action of Ginkgo biloba extract Egb 761², Methods in Enzymology. 1994, 234, 462-475.
4-67Shen, J. G.; Zhou, D. Y. ²Efficiency of Ginkgo biloba extract（Egb 761）antioxidant protection against myocardial ischemia and reperfusion injury². Biochemistry and Molecular Biology International. 1995, 35, 125-134.
4-68Ramassamy, C.; Averill, D.; Beffert, U.; Bastianetto, S.; Theroux, L.; Lussier-Cacan, S.; Cohn, J. S.; Christen, Y.; Davignon, J.; Quirion, R.; Poirier, J. ²Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer’s disease is related to the apolipoprotein E genotype², Free Radical Biology & Medicine. 1999, 27, 544-553.
4-69鄭慧文，中國時報第39版醫藥保健，1997年4月16日
4-70Busse, W.著、鄭綜程譯，「複葉銀杏的歷史與化學」，藥學雜誌，第12卷第1期，1996年3月，114-120頁。
4-71Aren, A.; Klein, M.; Fiehe, K.; Groβ, J.; Drewke, C.; Hemscheidt, T.; Leistner, E. ²Occurrence of neurotoxic 4΄-O-methylpyridoxine in Ginkgo biloba leaves, ginkgo medications and Japanese ginkgo food², Planta Medica. 1996, 62, 548-551.
4-72Li, C. L.; Wong, Y. Y. ²The bioavailability of ginkgolides in Ginkgo biloba extracts², Planta Med. 1997, 63, 563-565.
4-73King, M. B.; Bott, T. R. Extraction of natural products using near-critical solvents, 1st ed.; Chapman & Hall Press: UK, 1993.
4-74行政院衛生署網頁，http://www.doh.gov.tw/law/1/lawa15.htm.
4-75Ramsey, E. D.; ²Analytical supercritical fluid extraction techniques², Kluwer Academic Publishers: the Netherlands. 1998.
4-76Ashraf Khorassani, M.; Taylor, L. T. ²Supercritical fluid extraction of michellamines A and B from Ancistrocladus korupensis leaves², Anal. Chim Acta. 1997, 347, 305-311.
4-77Ling, Y. C.; Teng, H. C. ²Supercritical fluid extraction and clean-up of organochlorine pesticides and polychlorinated biphenyls in mussels², J. Chromatogr. A. 1997, 790, 153-160.
4-78郎慶勇、魏建謨、羅建苗、瞿港華，「超臨界流體萃取技術的應用與展望」，科儀新知，1999年，第20卷5期，90-97頁。4-79Bevan, C. D.; Marshall, P. S. ²The use of supercritical fluids in the isolation of natural products², Natural Product Reports. 1994, 11, 451-466.
4-80Modey, W. K.; Mulholland, D. A.; Raynor, M. W. ²Analytical supercritical fluid extraction of natural products², Phyochem. Anal. 1996, 7, 1-5.
4-81潘懷宗、林三吉、張光雄、李沐勳，「超臨界二氧化碳萃取十八種天然物之研究」，化學，1997年，第55卷第3期，19~23頁。4-82Jarvis, A. P.; Morgan, E. D. ²Isolation of plant products by supercritical-fluid extraction², Phyochem. Anal. 1997, 8, 217-222.
4-83Chen, Y. T.; Ling, Y. C. ²An overview of supercritical fluid extraction in Chinese herbal medicine：from preparation to analysis², Journal of Food and Drug Analysis. 2000, 8, 235-247.
4-84Lang, Q.; Wai, C. M. ²Supercritical fluid extraction in herbal and natural product studies─a practical review², Talanta. 2001, 53, 771-782.
4-85Abraham, M. A.; Sunol, A. K. ²Supercritical fluids extraction and pollution prevention², p 74, Washington, DC：American Chemical Society, 1997.
4-86鄧慧卿，「超臨界流體技術萃取中藥材、茶葉及貝類中有機氯化合物殘留量之分析研究」，國立清華大學碩士論文，1996年。
4-87Ibáñez, E.; López-Sebastián, S.; Romas, E.; Tabera, J.; Reglero, G. ²Analysis of highly volatile components of foods by off-line SFE/GC², J. Agric. Food Chem. 1997, 45, 3940-3943.
4-88Ibáñez, E.; Oca, A.; de Murga, G.; López-Sebastián, S.; Tabera, J.; Reglero, G. ²Supercritical fluid extraction and fractionation of different preprocessed rosemary plants², J. Agric. Food Chem. 1999, 47, 1400-1404.
4-89鷲尾泰俊原著，蔡明山編譯，「實驗計畫法」，1993年3月，修訂版三刷，華泰書局。
4-90Corey, E. J.; Su, W. G.; ² Total synthesis of a C-15 ginkgolide, (+/-)-bilobalide², J. Am. Chem. Soc. 1987, 109, 7534-7536.
4-91Corey, E. J.; Kang, M. C.; Desai, M. C.; Ghosh, A. K.; Houpis, I. N. ²Total synthesis of (+/-)-ginkgolide-b², J. Am. Chem. Soc. 1988, 110, 649-651.
4-92Carrier, D.J.; Chauret, N.; Mancini, M.; Coulombe, P.; Neufeld, R.; Weber, M.; Archambault, J. ²Detection of ginkgolide A in Ginkgo biloba cell cultures², Plant Cell Reports. 1991, 10, 256-259.
4-93Huh, H.; Staba, E. J. ²Ontogenic aspects of ginkgolide production in Ginkgo biloba², Planta Med. 1993, 59, 232-239.
4-94Jeon, M. H.; Sung, S. H.; Huh, H.; Kim, Y. C. ²Ginkgolide B in cultured cells derived from Ginkgo biloba leaves², Plant Cell Reports. 1995, 14, 501-504.
4-95van Beek, T. A.; Lelyveld, G. P. ²Preparative isolation and separation procedure for ginkgolide A, B, C, and J and bilobalide², J. Nat. Prod. 1997, 60, 735-738.
4-96Sticher, Q.; ²Quality of Ginkgo preparations², Planta Med. 1993, 59, 2-11.
4-97Lang, Q.; Wai, C. M. ²An extraction method for determination of ginkgolides and bilobalide in Ginkgo leaf extracts², Anal. Chem. 1999, 71, 2929-2933.
4-98van Beek, T. ²Comments on “An extraction method for determination of ginkgolides and bilobalide in Ginkgo leaf extracts ², Anal. Chem. 2000, 72, 3396.
4-99Van Beek, T.; Taylor, L. T. ²Sample preparation of standardized extracts of Ginkgo bilona by supercritical fluid extraction², Phytochem. Anal. 1996, 7, 185-191.
4-100Chen, P.; Su, X. L.; Nie, L. H.; Yao, S. Z.; Zeng, J. G. ²Analysis of ginkgolides and bilobalides in Ginkgo biloba L. extract for its production process control by high-performance liquid chromatography², J. Chromatogr. Sci. 1998, 36, 197-200.
4-101Pietta, P. G.; Mauri, P. L.; Rava, A. ²Analysis of terpenes from Ginkgo Biloba L. extracts by reversed phase high-performance liquid chromatography², Chromatographia. 1990, 29, 251-253.
4-102van Beek, T. A.; Scheeren, H. A.; Rantio, T.; Melger, W. Ch. Lelyveld, G. P. ²Determination of ginkgolides and bilobalide in Ginkgo biloba leaves and phytopharmaceuticals², J. Chromatogr. 1991, 543, 375-387.
4-103Hasler, A.; Sticher, O. ²Identification and determination of the flavonoids from Ginkgo biloba by high-performance liquid chromatography², J. Chromatogr. 1992, 605, 41-48.
4-104van Beek T. A.; Vanveldhuizen, A.; Lelyveld, G. P.; Piron I.; Lankhorst, P. P. ²Quantitation of bilobalide and ginkgolide-A, ginkgolide-B, ginkgolide-C and ginkgolide-J by means of nuclear-magnetic-resonance spectroscopy², Phytochem. Anal. 1993, 4, 261-268.
4-105van Beek T. A.; Lelyveld, G. P. ²Thin-layer chromatography of bilobalide and ginkgolide-A, ginkgolide-B, ginkgolide-C, and ginkgolide-J on sodium-acetate impregnated silica-gel², Phytochem. Anal. 1993, 4, 109-114.
4-106Oehrle, S. A. ²Analysis of ginkgolides and bilobalides by capillary electrophoresis², J. Liq. Chromatogr. 1995, 18, 2855-2859.
4-107Cauret, N.; Carrier, J.; Mancini, M.; Neufeld, R.; Weber, M.; Archambault, J. ²Gas chromatographic-mass spectrometric analysis of ginkgolides produced by Ginkgo biloba cell culture.², J. Chromatogr. 1991, 588, 281-287.
4-108Strode III, J. T. B.; Taylor, L. T.; van Beek, T. A. ²Supercritical fluid chromatography of ginkgolides A, B, C, and J and bilobalide², J. Chromotogr. A 1996, 738, 115-122.
4-109Maillard, M. P.; Wolfender J. L.; Hostettmann, K. ²Use of liquid-chromatography thermospray mass-spectrometry in phytochemical analysis of crude plant-extracts², J Chromatogr. 1993, 647, 147-154.
4-110Jimenez-Carmona, M. M.; Ubera, J. L.; Luque de Castro, M. D.; ²Comparison of continuous subcritical water extraction and hydrodistillation of marjoram essential oil², J. Chromatogr. A 1999, 855, 625-632.
4-111Sanagi, M. M.; Hung, W. P.; Yasir, S. M. ² Supercritical fluid extraction of pyrazines in roasted cocoa beans Effect of pod storage period², J. Chromatogr. A 1997, 785, 361-367.
4-112陳秋雲，「環境中多氯聯苯之分析：HRGC/ECD、MDGC/ECD、HRGC/LRMS與HRGC/IDMS方法的研究」，國立清華大學博士論文，1994年。
5-1郭城孟等著，「維管束植物簡誌第一卷蕨類植物門」，行政院農業委員會，1997年。
5-2Liu, J. S.; Zhu, Y. L. ²The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity², Can. J. Chem. 1986, 64, 837-839.
5-3Ayer, W. A.; Brown, L.; Qrszanska, H. ²Alkaloids of Lycopodium selago. On the identify of selagine with huperzine A and the structure of a alkaloid ², Can. J. Chem. 1989, 67, 1538-1540.
5-4Ayer, W. A.; Brown, L.; Kasitu, G. C. ²Some new Lycopodium alkaloids², Can. J. Chem. 1989, 67, 1077-1086.
5-5Bai, D. L. ²Traditional chinese medicines and new drug², Pure Appl. Chem. 1993, 65, 1103-1112.
5-6Ashani, Y.; Peggins III, J. O.; Doctor, B. P. ²Mechanism of inhibition of cholinesterases by huperzine A², Biochemical and Biophysical Research Communications. 1992, 184, 719-726.
5-7Cheng, D. H.; Ren, H.; Tang, X. C. ²Huperzine A, a novel promising acetylcholinesterase inhibitor², NeuroReport. 1996, 8, 97-101.
5-8Ved, H. S.; Koenig, M. L.; Dave, J. R.; Doctor, B. P. ²Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate², NeuroReport. 1997, 8, 963-968
5-9Wang, H.; Tang, X. C. ²Anticholinesterase effects of huperzine A, E2020, and tarcine in rats². Acta Pharmacol. Sin. 1998, 19，27-30。
5-10Kozikowski, A. P.; Tückmantel, W. ²Chemistry, pharmacology, and clinical efficacy of the Chinese nootropic agent huperzine A², Acc. Chem. Res. 1999, 32, 641-650.
5-11Bai, D. L.; Tang, X. C.; He, X. C. ²Huperzine A, a potential therapeutic agent for treatment of Alzheimer’s disease², Current Medicinal Chemistry. 2000, 355-374.
5-12Grunwald, L.; Raveh, L.; Doctor, B. P.; Ashani, Y. ²Huperzine A as a pretreatment candidate drug against nerve agent toxicity², Life Science. 1994, 54, 991-997.
5-13Prpping, J. ²Huperzine A², Am. J. Health-Syst. Pharm. 2000, 57, 530-534.
5-14Wang, H.; Tang, X. C. ²Anticholinesterase effects of huperzina A, E2020, and tacrine in rats², Acta Pharmacol. Sin. 1998, 19, 27-30.
5-15He, X. C.; Wang, B.; Bai, D. L. ² Studies on asymmetric synthesis of huperzine A ², Tetrahedron Letter. 1998, 39, 411-414.
5-16Geib, S. J. ²Huperzine A-a potent acetylcholinesterase inhibitor of use in the treatment of Alzheimer’s disease², Acta Cryst. 1991, C47, 824-827.
5-17Ashani, Y.; Peggins III, J. O.; Doctor, B. P. ²Mechanism of inhibition of cholinesterases by huperzine A², Biochemical and Biophysical Research Communications. 1992, 184, 719-726.
5-18Ashani. Y.; Grunwald. J.; Kronman, C.; Velan, B.; Shafferman. A. ²Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase², Molecular Pharmacology. 1994, 45, 555-560
5-19Raves, M. L.; Harel, M.; Pang, Y. P.; Silman, I.; Kozikowski, A. P.; Sussman, J. L. ²Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A², Nature Structural Biology. 1997, 4, 57-63.
5-20Kozikowski, A. P.; Xia, Y.; Reddy, E. R.; Tückmental, W.; Hamin, I.; Tang, X. C. ²Synthesis of huperzine A and its analogues and their anticholinesterase activity², J. Org. Chem., 1991, 56, 4636-4645.
5-21Xia, Y.; Kozikowski, A. P. ²A practical synthesis of the Chinese “Nootropic” agent huperzine A：a possible lead in the treatment of Alzhermer’s disease², J. Am. Chem. Soc. 1989, 111, 4116-4117.
5-22Yamada, F.; Kozikowski, A. P.; Reddy, E. R.; Pang, Y. P.; Miller, J. H.; Makinney, M. ²A route to optically pure (-)-huperzine A：molecular modeling and in vitro pharmacology², J. Am. Chem. Soc. 1991, 113, 4695-4696.
5-23Hanin, I.; Tang, X. C.; Kindel, G. L.; Kozikowski, A. P. ²Natural and synthetic huperzine A：effect on cholinergic function in vitro and in vivo², Ann. N. Y. Acad. Sci. 1993, 695, 304-306.
5-24Kanebo, S.; Yoshino, T.; Katoh, T.; Terashima, S. ²An enantioselective synthesis of natural (-)-huperzine A via chinchona alkaloids-promoted asymmetric Michael reaction², Heterocycle. 1997, 46, 27-30.
5-25張敏波，「高效液相色譜測定石杉鹼甲片的含量」，藥物分析雜誌，1997年，第17第5期，335-336頁。
5-26周芝芳、林志紅、謝譁、朱德振，「高效液相層析測定石杉鹼甲膠囊的含量」，藥物分析雜誌，1998年，第2期，104-106頁。
5-27Van Beek. T. A.; Taylor, L. T. ²Sample preparation of standardized extracts of Ginkgo biloba by supercritical fluid extraction², Phytochem. Anal. 1996, 7, 185-191.
5-28蘇瑀，「防治阿茲海默氏症之中草藥研發的現況及展望」，生物醫學報導，2001年，第7期，8-9頁。
5-29陳秋雲，「環境中多氯聯苯之分析：HRGC/ECD、MDGC/ECD、HRGC/LRMS與HRGC/IDMS方法的研究」，國立清華大學博士論文，1994年。